Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q2 2019 · 10-Q
Revenue—
Net Income-$4.81M-$4.81MN/M vs Q2 2018 EPS Diluted-$0.10-$0.10N/M vs Q2 2018 Operating Income-$4,904,854N/M Operating Cash Flowderived-$3,487,946N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end